Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Is HRT appropriate after risk-reducing surgery in BRCA mutation carriers with a history of triple-negative breast cancer? What do current international guidelines, evidence, and expert recommendations suggest?
Although colonic metastases from breast cancer are extremely rare, it is important for patients with a history of breast cancer who present with GI symptoms to undergo prompt endoscopic evaluation.
Explore the current knowledge of breast cancer brain metastases, from metastatic mechanisms to tumor microenvironment interactions, and learn how this understanding is driving diagnostic and therapeutic developments.
This case of subacute inferolateral myocardial infarction secondary to coronary thrombosis occurring after adjuvant doxorubicin–cyclophosphamide therapy in a patient with breast cancer underscores the need for vigilance for uncommon, yet life-threatening, complications.
Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.
In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.
Please note, this webinar is not intended for healthcare professionals based in the US and UK.
Although colonic metastases from breast cancer are extremely rare, it is important for patients with a history of breast cancer who present with GI symptoms to undergo prompt endoscopic evaluation.
This case of subacute inferolateral myocardial infarction secondary to coronary thrombosis occurring after adjuvant doxorubicin–cyclophosphamide therapy in a patient with breast cancer underscores the need for vigilance for uncommon, yet life-threatening, complications.
A rare occurrence of four primary malignancies – bilateral breast cancer, ovarian cancer, and undifferentiated high-grade pleomorphic sarcoma. Could the patient have a hereditary cancer syndrome?
Breast cancer is the most prevalent malignancy in women throughout the world, with a high level of heterogeneity concerning the subtypes, posing challenges to long-term treatment success. Among the emerging therapeutic strategies, poly …
Antibody-drug conjugates (ADCs) represent a major advance in breast cancer therapy, with trastuzumab deruxtecan and sacituzumab govitecan emerging as leading agents targeting distinct tumor antigens and employing different linker-payload designs.
Breast cancer disparities in outcomes remain a persistent challenge in the USA, with survival influenced by neighborhood context, access to resources, and the applicability of existing scientific evidence across populations. These disparities …
POSITIVEly reassuring results from a clinical trial
The POSITIVE trial previously showed that women with breast cancer can safely interrupt endocrine therapy in order to become pregnant. But what about breastfeeding - is that possible and safe for the mother and baby?
Women can take heart from the latest findings, says Dr. Cristina Saura, as she takes us through these important clinical updates.
Breast cancer prevalence has been increasing worldwide, including Japan [ 1 ]. In early-stage breast cancer, intravenous vesicant chemotherapy is often administered perioperatively as the primary treatment [ 2 ]. Extravasation is the most serious …
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has the highest sensitivity for detecting breast cancer among current clinical imaging modalities [ 1 ]. However, after administration of intravenous contrast media, in addition to …
Antibody-drug conjugates (ADCs) represent a major advance in breast cancer therapy, with trastuzumab deruxtecan and sacituzumab govitecan emerging as leading agents targeting distinct tumor antigens and employing different linker-payload designs.